Article Text
Statistics from Altmetric.com
There is a growing relationship between BASHH and IUSTI.1 In 2023, several BASHH scholars were invited to give feedback on the IUSTI conference in Malta.
Asymptomatic STI screening: Chris Kenyon, (Belgium)
Despite good evidence for HIV and syphilis screening in asymptomatic patients, evidence is lacking for other STIs, for example, Neisseria gonorrhoeae and Chlamydia trachomatis. Kenyon et al 2 highlighted the potential harms of widespread screening for asymptomatic STIs, particularly in HIV-pre-exposure prophylaxis (HIV-PrEP) cohorts, namely increased antimicrobial consumption and antimicrobial resistance (AMR). In Belgium, clinics have reduced asymptomatic STI screening in men who have sex with men using HIV-PrEP: what we need now are patient perspectives and involvement if we are to reduce screening in an attempt to curtail AMR.
STIs in teenagers & adolescents: Errol Fields, (USA)
Fields et al 3 presented interventions developed in Baltimore, USA, to …
Footnotes
Handling editor Anna Maria Geretti
Contributors DR and RJC conceived this BASHH column, DR drafted the section on asymptomatic STI testing, MB drafted the section on STIs in teenagers and adolescents, OBO drafted the section on doxycycline for STI prophylaxis, NG drafted the section on non-fatal strangulation, FN drafted the section on genital dermatoses, BS drafted the section on hepatitis B. DR, MB, OBO, NG, FN, BS and RJC all contributed to the final manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests DR, MB, OBO, NG, FN and BS received BASHH scholarships to attend the IUSTI conference in Malta.
Provenance and peer review Not commissioned; internally peer reviewed.